Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Teladoc Health, Inc.TDOC · Entity 1547 | CHIEF LEGAL OFFICER, SECRETARY | September 01, 2026 | September 03, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Teladoc Health, Inc.
Report date September 01, 2026 · Filed September 03, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 117,616 |
Ending reported balance
After 2026-09-02 transaction · row 4
4 source rows · reconciled sequenceRow 1 · 2026-09-01 · Exercise / conversion · Acquired 5,350 · Balance 115,611 F1: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. Row 2 · 2026-09-01 · Exercise / conversion · Acquired 9,152 · Balance 124,763 F1: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. Row 3 · 2026-09-01 · Exercise / conversion · Acquired 426 · Balance 125,189 F2: Performance stock units convert to shares of TDOC common stock on a one-for-one basis. Row 4 · 2026-09-02 · Sale · Disposed 7,573 · Balance 117,616 F3: Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's performance stock unit and restricted stock unit awards. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 10,700 |
Reported balance
After 2026-09-01 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2026-09-01 · Exercise / conversion · Disposed 5,350 · Balance 10,700 F1: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. F4: On March 19, 2024, the reporting person was granted 64,200 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments beginning on June 1, 2025. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 54,918 |
Reported balance
After 2026-09-01 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2026-09-01 · Exercise / conversion · Disposed 9,152 · Balance 54,918 F1: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. F5: On March 1, 2025, the reporting person was granted 109,832 restricted stock units, vesting one-third on March 1, 2026, with the remainder vesting in eight substantially equal quarterly installments thereafter. |
| Performance Stock UnitsSEC Table II · derivative / convertible security | Direct | 2,553 |
Reported balance
After 2026-09-01 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2026-09-01 · Exercise / conversion · Disposed 426 · Balance 2,553 F2: Performance stock units convert to shares of TDOC common stock on a one-for-one basis. F6: On March 1, 2026, the reporting person earned 5,107 performance stock units, vesting one-third on March 1, 2026, with the remainder vesting in eight substantially equal quarterly installments thereafter. |
Filing footnotes · ownership attribution and instrument terms
F1: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.
F2: Performance stock units convert to shares of TDOC common stock on a one-for-one basis.
F3: Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's performance stock unit and restricted stock unit awards.
F4: On March 19, 2024, the reporting person was granted 64,200 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments beginning on June 1, 2025.
F5: On March 1, 2025, the reporting person was granted 109,832 restricted stock units, vesting one-third on March 1, 2026, with the remainder vesting in eight substantially equal quarterly installments thereafter.
F6: On March 1, 2026, the reporting person earned 5,107 performance stock units, vesting one-third on March 1, 2026, with the remainder vesting in eight substantially equal quarterly installments thereafter.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 04, 2021 Filed Mar 5, 2021 22:31 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionPerformance Stock Units · Derivative | 4,489 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-21-002991 · edgar.xml · derivative · entry 13 Vandervoort Adam C · CIK 0001375088 · Chief Legal Officer, Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,491 Underlying: Common Stock · 4,489 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_price: Performance stock units convert to shares of TDOC common stock on a one-for-one basis. F10 · derivative.exercise_date: On February 26, 2020, the reporting person earned 13,471 performance stock units, vesting in three substantially equal annual installments beginning on March 4, 2020. The number of performance stock units earned has been decreased by one due to a rounding error on the reporting person's Form 4 that was filed on February 28, 2020. F10 · derivative.expiration_date: On February 26, 2020, the reporting person earned 13,471 performance stock units, vesting in three substantially equal annual installments beginning on March 4, 2020. The number of performance stock units earned has been decreased by one due to a rounding error on the reporting person's Form 4 that was filed on February 28, 2020. F10 · balance_after: On February 26, 2020, the reporting person earned 13,471 performance stock units, vesting in three substantially equal annual installments beginning on March 4, 2020. The number of performance stock units earned has been decreased by one due to a rounding error on the reporting person's Form 4 that was filed on February 28, 2020. Read SEC document |
| March 04, 2021 Filed Mar 5, 2021 22:31 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionRestricted Stock Units · Derivative | 3,455 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-21-002991 · edgar.xml · derivative · entry 12 Vandervoort Adam C · CIK 0001375088 · Chief Legal Officer, Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,454 Underlying: Common Stock · 3,455 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. F9 · derivative.exercise_date: On March 4, 2019, the reporting person was granted 10,363 restricted stock units, vesting in three substantially equal annual installments beginning on the first anniversary of the grant date. F9 · derivative.expiration_date: On March 4, 2019, the reporting person was granted 10,363 restricted stock units, vesting in three substantially equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| March 04, 2021 Filed Mar 5, 2021 22:31 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 4,489 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001179110-21-002991 · edgar.xml · nonDerivative · entry 8 Vandervoort Adam C · CIK 0001375088 · Chief Legal Officer, Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,750 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · price: Performance stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| March 04, 2021 Filed Mar 5, 2021 22:31 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 3,455 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001179110-21-002991 · edgar.xml · nonDerivative · entry 7 Vandervoort Adam C · CIK 0001375088 · Chief Legal Officer, Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,261 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| March 04, 2021 Filed Mar 5, 2021 22:31 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 970 | $200.48 | $194,460.75 |
DisclosureSEC source: 0001179110-21-002991 · edgar.xml · nonDerivative · entry 6 Vandervoort Adam C · CIK 0001375088 · Chief Legal Officer, Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,806 F7 · shares: Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's restricted stock unit awards. Read SEC document |
| March 03, 2021 Filed Mar 5, 2021 22:31 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionRestricted Stock Units · Derivative | 1,953 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-21-002991 · edgar.xml · derivative · entry 11 Vandervoort Adam C · CIK 0001375088 · Chief Legal Officer, Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,953 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. F6 · derivative.exercise_date: On May 25, 2017, the reporting person was granted 7,811 restricted stock units, vesting in four substantially equal annual installments beginning on March 3, 2018. F6 · derivative.expiration_date: On May 25, 2017, the reporting person was granted 7,811 restricted stock units, vesting in four substantially equal annual installments beginning on March 3, 2018. Read SEC document |
| March 03, 2021 Filed Mar 5, 2021 22:31 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 1,165 | $0.00 Strike: $38.55 | $0.00 |
DisclosureSEC source: 0001179110-21-002991 · edgar.xml · derivative · entry 10 Vandervoort Adam C · CIK 0001375088 · Chief Legal Officer, Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,058 Underlying: Common Stock · 1,165 shares Expires 2028-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The option vested as to 25% of the shares on March 1, 2019. The remainder of the shares vest in 36 equal monthly installments thereafter. Read SEC document |
| March 03, 2021 Filed Mar 5, 2021 22:31 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 1,447 | $0.00 Strike: $22.30 | $0.00 |
DisclosureSEC source: 0001179110-21-002991 · edgar.xml · derivative · entry 9 Vandervoort Adam C · CIK 0001375088 · Chief Legal Officer, Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,447 shares Expires 2027-03-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The option vested as to 25% of the shares on March 3, 2018. The remainder of the shares vest in 36 equal monthly installments thereafter. Read SEC document |
| March 03, 2021 Filed Mar 5, 2021 22:31 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 1,953 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001179110-21-002991 · edgar.xml · nonDerivative · entry 5 Vandervoort Adam C · CIK 0001375088 · Chief Legal Officer, Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,776 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| March 03, 2021 Filed Mar 5, 2021 22:31 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 2,612 | $214.63 | $560,613.56 |
DisclosureSEC source: 0001179110-21-002991 · edgar.xml · nonDerivative · entry 4 Vandervoort Adam C · CIK 0001375088 · Chief Legal Officer, Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,823 F2 · shares: This transaction was effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on April 16, 2020. Read SEC document |
| March 03, 2021 Filed Mar 5, 2021 22:31 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 1,165 | $38.55 | $44,910.75 |
DisclosureSEC source: 0001179110-21-002991 · edgar.xml · nonDerivative · entry 3 Vandervoort Adam C · CIK 0001375088 · Chief Legal Officer, Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,435 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · shares: This transaction was effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on April 16, 2020. Read SEC document |
| March 03, 2021 Filed Mar 5, 2021 22:31 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 1,447 | $22.30 | $32,268.10 |
DisclosureSEC source: 0001179110-21-002991 · edgar.xml · nonDerivative · entry 2 Vandervoort Adam C · CIK 0001375088 · Chief Legal Officer, Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,270 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · shares: This transaction was effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on April 16, 2020. Read SEC document |
| March 03, 2021 Filed Mar 5, 2021 22:31 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 2,705 | $206.99 | $559,907.95 |
DisclosureSEC source: 0001179110-21-002991 · edgar.xml · nonDerivative · entry 1 Vandervoort Adam C · CIK 0001375088 · Chief Legal Officer, Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,823 F1 · shares: Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's restricted stock unit and performance stock unit awards. Read SEC document |
| March 02, 2021 Filed Mar 4, 2021 01:07 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | GrantRestricted Stock Units · Derivative | 5,736 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-21-002812 · edgar.xml · derivative · entry 9 Vandervoort Adam C · CIK 0001375088 · Chief Legal Officer, Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,736 Underlying: Common Stock · 5,736 shares Expires not disclosed F10 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of TDOC common stock. F11 · derivative.exercise_date: The restricted stock units vest in three substantially equal annual installments beginning on the first anniversary of the grant date. F11 · derivative.expiration_date: The restricted stock units vest in three substantially equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| March 02, 2021 Filed Mar 4, 2021 01:07 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionPerformance Stock Units · Derivative | 3,300 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-21-002812 · edgar.xml · derivative · entry 8 Vandervoort Adam C · CIK 0001375088 · Chief Legal Officer, Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,600 Underlying: Common Stock · 3,300 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Performance stock units convert to shares of TDOC common stock on a one-for-one basis. F9 · derivative.exercise_date: On March 2, 2021, the reporting person earned 9,900 performance stock units, vesting in three substantially equal annual installments beginning on March 2, 2021. F9 · derivative.expiration_date: On March 2, 2021, the reporting person earned 9,900 performance stock units, vesting in three substantially equal annual installments beginning on March 2, 2021. Read SEC document |
| March 02, 2021 Filed Mar 4, 2021 01:07 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | GrantPerformance Stock Units · Derivative | 9,900 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-21-002812 · edgar.xml · derivative · entry 7 Vandervoort Adam C · CIK 0001375088 · Chief Legal Officer, Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,900 Underlying: Common Stock · 9,900 shares Expires not disclosed F6 · derivative.exercise_price: Each performance stock unit represents a contingent right to receive one share of TDOC common stock. F7 · shares: Performance award amount determined based on metrics in respect of the issuer's 2020 financial results. F8 · derivative.exercise_date: The performance stock units vest in three substantially equal annual installments beginning on March 2, 2021. F8 · derivative.expiration_date: The performance stock units vest in three substantially equal annual installments beginning on March 2, 2021. Read SEC document |
| March 02, 2021 Filed Mar 4, 2021 01:07 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionRestricted Stock Units · Derivative | 1,941 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-21-002812 · edgar.xml · derivative · entry 6 Vandervoort Adam C · CIK 0001375088 · Chief Legal Officer, Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,883 Underlying: Common Stock · 1,941 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. F5 · derivative.exercise_date: On March 2, 2020, the reporting person was granted 5,824 restricted stock units, vesting in three substantially equal annual installments beginning on the first anniversary of the grant date. F5 · derivative.expiration_date: On March 2, 2020, the reporting person was granted 5,824 restricted stock units, vesting in three substantially equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| March 02, 2021 Filed Mar 4, 2021 01:07 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 3,300 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001179110-21-002812 · edgar.xml · nonDerivative · entry 4 Vandervoort Adam C · CIK 0001375088 · Chief Legal Officer, Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,528 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · price: Performance stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| March 02, 2021 Filed Mar 4, 2021 01:07 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 1,941 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001179110-21-002812 · edgar.xml · nonDerivative · entry 3 Vandervoort Adam C · CIK 0001375088 · Chief Legal Officer, Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,228 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| March 02, 2021 Filed Mar 4, 2021 01:07 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 1,658 | $224.28 | $371,859.56 |
DisclosureSEC source: 0001179110-21-002812 · edgar.xml · nonDerivative · entry 2 Vandervoort Adam C · CIK 0001375088 · Chief Legal Officer, Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,287 F2 · shares: Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's restricted stock unit awards. Read SEC document |
| March 01, 2021 Filed Mar 4, 2021 01:07 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionRestricted Stock Units · Derivative | 3,745 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-21-002812 · edgar.xml · derivative · entry 5 Vandervoort Adam C · CIK 0001375088 · Chief Legal Officer, Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,745 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. F4 · derivative.exercise_date: On March 1, 2018, the reporting person was granted 11,236 restricted stock units, vesting in three substantially equal annual installments beginning on the first anniversary of the grant date. F4 · derivative.expiration_date: On March 1, 2018, the reporting person was granted 11,236 restricted stock units, vesting in three substantially equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| March 01, 2021 Filed Mar 4, 2021 01:07 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 3,745 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001179110-21-002812 · edgar.xml · nonDerivative · entry 1 Vandervoort Adam C · CIK 0001375088 · Chief Legal Officer, Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,945 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| February 03, 2021 Filed Feb 4, 2021 21:05 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 1,164 | $0.00 Strike: $38.55 | $0.00 |
DisclosureSEC source: 0001179110-21-001317 · edgar.xml · derivative · entry 5 Vandervoort Adam C · CIK 0001375088 · Chief Legal Officer, Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,223 Underlying: Common Stock · 1,164 shares Expires 2028-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option vested as to 25% of the shares on March 1, 2019. The remainder of the shares vest in 36 equal monthly installments thereafter. Read SEC document |
| February 03, 2021 Filed Feb 4, 2021 21:05 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 1,446 | $0.00 Strike: $22.30 | $0.00 |
DisclosureSEC source: 0001179110-21-001317 · edgar.xml · derivative · entry 4 Vandervoort Adam C · CIK 0001375088 · Chief Legal Officer, Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,447 Underlying: Common Stock · 1,446 shares Expires 2027-03-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option vested as to 25% of the shares on March 3, 2018. The remainder of the shares vest in 36 equal monthly installments thereafter. Read SEC document |
| February 03, 2021 Filed Feb 4, 2021 21:05 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 2,610 | $269.85 | $704,308.50 |
DisclosureSEC source: 0001179110-21-001317 · edgar.xml · nonDerivative · entry 3 Vandervoort Adam C · CIK 0001375088 · Chief Legal Officer, Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 200 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on March 16, 2020. Read SEC document |
| February 03, 2021 Filed Feb 4, 2021 21:05 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 1,164 | $38.55 | $44,872.20 |
DisclosureSEC source: 0001179110-21-001317 · edgar.xml · nonDerivative · entry 2 Vandervoort Adam C · CIK 0001375088 · Chief Legal Officer, Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,810 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 03, 2021 Filed Feb 4, 2021 21:05 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 1,446 | $22.30 | $32,245.80 |
DisclosureSEC source: 0001179110-21-001317 · edgar.xml · nonDerivative · entry 1 Vandervoort Adam C · CIK 0001375088 · Chief Legal Officer, Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,646 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 04, 2021 Filed Jan 6, 2021 21:10 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 1,082 | $0.00 Strike: $38.55 | $0.00 |
DisclosureSEC source: 0001179110-21-000316 · edgar.xml · derivative · entry 5 Vandervoort Adam C · CIK 0001375088 · Chief Legal Officer, Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,387 Underlying: Common Stock · 1,082 shares Expires 2028-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option vested as to 25% of the shares on March 1, 2019. The remainder of the shares vest in 36 equal monthly installments thereafter. Read SEC document |
| January 04, 2021 Filed Jan 6, 2021 21:10 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 1,447 | $0.00 Strike: $22.30 | $0.00 |
DisclosureSEC source: 0001179110-21-000316 · edgar.xml · derivative · entry 4 Vandervoort Adam C · CIK 0001375088 · Chief Legal Officer, Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,893 Underlying: Common Stock · 1,447 shares Expires 2027-03-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option vested as to 25% of the shares on March 3, 2018. The remainder of the shares vest in 36 equal monthly installments thereafter. Read SEC document |
| January 04, 2021 Filed Jan 6, 2021 21:10 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 2,529 | $199.80 | $505,294.20 |
DisclosureSEC source: 0001179110-21-000316 · edgar.xml · nonDerivative · entry 3 Vandervoort Adam C · CIK 0001375088 · Chief Legal Officer, Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 200 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on March 16, 2020. Read SEC document |
| January 04, 2021 Filed Jan 6, 2021 21:10 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 1,082 | $38.55 | $41,711.10 |
DisclosureSEC source: 0001179110-21-000316 · edgar.xml · nonDerivative · entry 2 Vandervoort Adam C · CIK 0001375088 · Chief Legal Officer, Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,729 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 04, 2021 Filed Jan 6, 2021 21:10 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 1,447 | $22.30 | $32,268.10 |
DisclosureSEC source: 0001179110-21-000316 · edgar.xml · nonDerivative · entry 1 Vandervoort Adam C · CIK 0001375088 · Chief Legal Officer, Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,647 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 03, 2020 Filed Dec 7, 2020 21:02 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 1,164 | $0.00 Strike: $38.50 | $0.00 |
DisclosureSEC source: 0001179110-20-011719 · edgar.xml · derivative · entry 5 Vandervoort Adam C · CIK 0001375088 · Chief Legal Officer, Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,469 Underlying: Common Stock · 1,164 shares Expires 2028-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option vested as to 25% of the shares on March 1, 2019. The remainder of the shares vest in 36 equal monthly installments thereafter. Read SEC document |
| December 03, 2020 Filed Dec 7, 2020 21:02 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 1,447 | $0.00 Strike: $22.30 | $0.00 |
DisclosureSEC source: 0001179110-20-011719 · edgar.xml · derivative · entry 4 Vandervoort Adam C · CIK 0001375088 · Chief Legal Officer, Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,340 Underlying: Common Stock · 1,447 shares Expires 2027-03-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option vested as to 25% of the shares on March 3, 2018. The remainder of the shares vest in 36 equal monthly installments thereafter. Read SEC document |
| December 03, 2020 Filed Dec 7, 2020 21:02 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 2,611 | $196.50 | $513,061.50 |
DisclosureSEC source: 0001179110-20-011719 · edgar.xml · nonDerivative · entry 3 Vandervoort Adam C · CIK 0001375088 · Chief Legal Officer, Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 200 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on March 16, 2020. Read SEC document |
| December 03, 2020 Filed Dec 7, 2020 21:02 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 1,164 | $38.50 | $44,814.00 |
DisclosureSEC source: 0001179110-20-011719 · edgar.xml · nonDerivative · entry 2 Vandervoort Adam C · CIK 0001375088 · Chief Legal Officer, Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,811 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 03, 2020 Filed Dec 7, 2020 21:02 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 1,447 | $22.30 | $32,268.10 |
DisclosureSEC source: 0001179110-20-011719 · edgar.xml · nonDerivative · entry 1 Vandervoort Adam C · CIK 0001375088 · Chief Legal Officer, Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,647 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 03, 2020 Filed Nov 5, 2020 21:03 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 1,165 | $0.00 Strike: $38.55 | $0.00 |
DisclosureSEC source: 0001179110-20-010832 · edgar.xml · derivative · entry 5 Vandervoort Adam C · CIK 0001375088 · Chief Legal Officer, Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,633 Underlying: Common Stock · 1,165 shares Expires 2028-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option vested as to 25% of the shares on March 1, 2019. The remainder of the shares vest in 36 equal monthly installments thereafter. Read SEC document |
| November 03, 2020 Filed Nov 5, 2020 21:03 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 1,447 | $0.00 Strike: $22.30 | $0.00 |
DisclosureSEC source: 0001179110-20-010832 · edgar.xml · derivative · entry 4 Vandervoort Adam C · CIK 0001375088 · Chief Legal Officer, Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,787 Underlying: Common Stock · 1,447 shares Expires 2027-03-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option vested as to 25% of the shares on March 3, 2018. The remainder of the shares vest in 36 equal monthly installments thereafter. Read SEC document |
| November 03, 2020 Filed Nov 5, 2020 21:03 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 2,612 | $192.00 | $501,504.00 |
DisclosureSEC source: 0001179110-20-010832 · edgar.xml · nonDerivative · entry 3 Vandervoort Adam C · CIK 0001375088 · Chief Legal Officer, Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 200 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on March 16, 2020. Read SEC document |
| November 03, 2020 Filed Nov 5, 2020 21:03 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 1,165 | $38.55 | $44,910.75 |
DisclosureSEC source: 0001179110-20-010832 · edgar.xml · nonDerivative · entry 2 Vandervoort Adam C · CIK 0001375088 · Chief Legal Officer, Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,812 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 03, 2020 Filed Nov 5, 2020 21:03 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 1,447 | $22.30 | $32,268.10 |
DisclosureSEC source: 0001179110-20-010832 · edgar.xml · nonDerivative · entry 1 Vandervoort Adam C · CIK 0001375088 · Chief Legal Officer, Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,647 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 05, 2020 Filed Oct 6, 2020 20:12 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 1,164 | $0.00 Strike: $38.55 | $0.00 |
DisclosureSEC source: 0001179110-20-010309 · edgar.xml · derivative · entry 5 Vandervoort Adam C · CIK 0001375088 · Chief Legal Officer, Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,798 Underlying: Common Stock · 1,164 shares Expires 2028-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option vested as to 25% of the shares on March 1, 2019. The remainder of the shares vest in 36 equal monthly installments thereafter. Read SEC document |
| October 05, 2020 Filed Oct 6, 2020 20:12 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 1,446 | $0.00 Strike: $22.30 | $0.00 |
DisclosureSEC source: 0001179110-20-010309 · edgar.xml · derivative · entry 4 Vandervoort Adam C · CIK 0001375088 · Chief Legal Officer, Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,234 Underlying: Common Stock · 1,446 shares Expires 2027-03-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option vested as to 25% of the shares on March 3, 2018. The remainder of the shares vest in 36 equal monthly installments thereafter. Read SEC document |
| October 05, 2020 Filed Oct 6, 2020 20:12 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 2,610 | $222.46 | $580,620.60 |
DisclosureSEC source: 0001179110-20-010309 · edgar.xml · nonDerivative · entry 3 Vandervoort Adam C · CIK 0001375088 · Chief Legal Officer, Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 200 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on March 16, 2020. Read SEC document |
| October 05, 2020 Filed Oct 6, 2020 20:12 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 1,164 | $38.55 | $44,872.20 |
DisclosureSEC source: 0001179110-20-010309 · edgar.xml · nonDerivative · entry 2 Vandervoort Adam C · CIK 0001375088 · Chief Legal Officer, Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,810 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 05, 2020 Filed Oct 6, 2020 20:12 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 1,446 | $22.30 | $32,245.80 |
DisclosureSEC source: 0001179110-20-010309 · edgar.xml · nonDerivative · entry 1 Vandervoort Adam C · CIK 0001375088 · Chief Legal Officer, Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,646 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 03, 2020 Filed Sep 8, 2020 20:18 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 1,165 | $0.00 Strike: $38.55 | $0.00 |
DisclosureSEC source: 0001179110-20-009620 · edgar.xml · derivative · entry 5 Vandervoort Adam C · CIK 0001375088 · Chief Legal Officer, Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,962 Underlying: Common Stock · 1,165 shares Expires 2028-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option vested as to 25% of the shares on March 1, 2019. The remainder of the shares vest in 36 equal monthly installments thereafter Read SEC document |
| September 03, 2020 Filed Sep 8, 2020 20:18 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 1,447 | $0.00 Strike: $22.30 | $0.00 |
DisclosureSEC source: 0001179110-20-009620 · edgar.xml · derivative · entry 4 Vandervoort Adam C · CIK 0001375088 · Chief Legal Officer, Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,680 Underlying: Common Stock · 1,447 shares Expires 2027-03-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option vested as to 25% of the shares on March 3, 2018. The remainder of the shares vest in 36 equal monthly installments thereafter. Read SEC document |
| September 03, 2020 Filed Sep 8, 2020 20:18 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 2,612 | $213.10 | $556,617.20 |
DisclosureSEC source: 0001179110-20-009620 · edgar.xml · nonDerivative · entry 3 Vandervoort Adam C · CIK 0001375088 · Chief Legal Officer, Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 200 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on March 16, 2020. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.